284 related articles for article (PubMed ID: 28224645)
1. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
Amkreutz J; Koch A; Buendgens L; Trautwein C; Eisert A
J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and nature of potential drug-drug interactions among kidney transplant patients in a German intensive care unit.
Amkreutz J; Koch A; Buendgens L; Muehlfeld A; Trautwein C; Eisert A
Int J Clin Pharm; 2017 Oct; 39(5):1128-1139. PubMed ID: 28823018
[TBL] [Abstract][Full Text] [Related]
3. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
[TBL] [Abstract][Full Text] [Related]
4. The effect of ICU-tailored drug-drug interaction alerts on medication prescribing and monitoring: protocol for a cluster randomized stepped-wedge trial.
Bakker T; Klopotowska JE; Eslami S; de Lange DW; van Marum R; van der Sijs H; de Jonge E; Dongelmans DA; de Keizer NF; Abu-Hanna A
BMC Med Inform Decis Mak; 2019 Aug; 19(1):159. PubMed ID: 31409338
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study.
Bakker T; Abu-Hanna A; Dongelmans DA; Vermeijden WJ; Bosman RJ; de Lange DW; Klopotowska JE; de Keizer NF; ; Hendriks S; Ten Cate J; Schutte PF; van Balen D; Duyvendak M; Karakus A; Sigtermans M; Kuck EM; Hunfeld NGM; van der Sijs H; de Feiter PW; Wils EJ; Spronk PE; van Kan HJM; van der Steen MS; Purmer IM; Bosma BE; Kieft H; van Marum RJ; de Jonge E; Beishuizen A; Movig K; Mulder F; Franssen EJF; van den Bergh WM; Bult W; Hoeksema M; Wesselink E
J Crit Care; 2021 Apr; 62():124-130. PubMed ID: 33352505
[TBL] [Abstract][Full Text] [Related]
7. Frequency and nature of drug-drug interactions in the intensive care unit.
Askari M; Eslami S; Louws M; Wierenga PC; Dongelmans DA; Kuiper RA; Abu-Hanna A
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):430-7. PubMed ID: 23420793
[TBL] [Abstract][Full Text] [Related]
8. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
Hecker M; Frahm N; Bachmann P; Debus JL; Haker MC; Mashhadiakbar P; Langhorst SE; Baldt J; Streckenbach B; Heidler F; Zettl UK
Front Pharmacol; 2022; 13():946351. PubMed ID: 36034780
[No Abstract] [Full Text] [Related]
9. Drug-drug interactions in the intensive care unit: Do they really matter?
Vanham D; Spinewine A; Hantson P; Wittebole X; Wouters D; Sneyers B
J Crit Care; 2017 Apr; 38():97-103. PubMed ID: 27883969
[TBL] [Abstract][Full Text] [Related]
10. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of potential drug-drug interactions in intensive care unit.
Dagdelen MS; Gulen D; Ceylan I; Girgin NK
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients.
Zorina OI; Haueis P; Semmler A; Marti I; Gonzenbach RR; Guzek M; Kullak-Ublick GA; Weller M; Russmann S
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):872-80. PubMed ID: 22517594
[TBL] [Abstract][Full Text] [Related]
13. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients.
Zhang J; Ma D; Chen M; Hu Y; Chen X; Chen J; Huang M; Dai H
Front Pharmacol; 2024; 15():1308260. PubMed ID: 38379901
[No Abstract] [Full Text] [Related]
15. Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists.
Askari M; Eslami S; Louws M; Dongelmans D; Wierenga P; Kuiper R; Abu-Hanna A
Stud Health Technol Inform; 2012; 180():716-20. PubMed ID: 22874285
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources.
Pehlivanli A; Eren-Sadioglu R; Aktar M; Eyupoglu S; Sengul S; Keven K; Erturk S; Basgut B; Ozcelikay AT
Int J Clin Pharm; 2022 Jun; 44(3):651-662. PubMed ID: 35235113
[TBL] [Abstract][Full Text] [Related]
17. Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.
Bakker T; Klopotowska JE; de Keizer NF; van Marum R; van der Sijs H; de Lange DW; de Jonge E; Abu-Hanna A; Dongelmans DA;
J Crit Care; 2020 Jun; 57():134-140. PubMed ID: 32145656
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.
Fitzmaurice MG; Wong A; Akerberg H; Avramovska S; Smithburger PL; Buckley MS; Kane-Gill SL
Drug Saf; 2019 Sep; 42(9):1035-1044. PubMed ID: 31098917
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions in hospitalized pediatric patients with respiratory disorders: a retrospective review of clinically important interactions.
Hassanzad M; Tashayoie Nejad S; Mahboobipour AA; Salem F; Baniasadi S
Drug Metab Pers Ther; 2020 Jan; 35(1):. PubMed ID: 32004144
[TBL] [Abstract][Full Text] [Related]
20. Potential Drug-Drug Interactions in a Cohort of Elderly, Polymedicated Primary Care Patients on Antithrombotic Treatment.
Schneider KL; Kastenmüller K; Weckbecker K; Bleckwenn M; Böhme M; Stingl JC
Drugs Aging; 2018 Jun; 35(6):559-568. PubMed ID: 29737468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
